5 Stocks Under Wall Street’s Radar: TransAct Technologies Incorporated (NASDAQ:TACT), Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ), Huntsman Corporation (NYSE:HUN),

TransAct Technologies Incorporated (NASDAQ:TACT) announced that its Board of Directors has approved a $5.0 million stock repurchase program. TransAct is now authorized to repurchase up to $5.0 million of its outstanding shares of common stock from time to time on the open market, depending on market conditions, share price and other factors. The share repurchase authorization expires on December 31, 2017.

TransAct Technologies Incorporated (NASDAQ:TACT) belongs to Technology sector. Its net profit margin is -0.80% and weekly performance is 7.15%. On last trading day company shares ended up at $7.49. TransAct Technologies Incorporated (NASDAQ:TACT) distance from 50-day simple moving average (SMA50) is 1.27%.

Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) announced that it will report its 2015 fourth quarter and full-year financial results on Tuesday, March 15, 2016, before the opening of the U.S. financial markets. Following the announcement, executive management will host a conference call and webcast at 8:30 a.m. ET that day to discuss the financial results, recent highlights and guidance for 2016 financial results.

Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) shares fell -4.23% in last trading session and ended the day at $5.43. Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) quarterly performance is -25.41%.

Huntsman Corporation (NYSE:HUN)‘s stock had its “buy” rating restated by Jefferies Group in a report issued on Tuesday, Market Beat reports. They currently have a $17.00 price target on the stock. Jefferies Group’s price objective would suggest a potential upside of 56.54% from the stock’s current price.

On 01 March, Huntsman Corporation (NYSE:HUN) shares moved up 3.13% and was closed at $11.20. HUN EPS growth in last 5 year was 54.00%. Huntsman Corporation (NYSE:HUN) year to date (YTD) performance is -1.50%.

Arrowhead Research Corp. (NASDAQ:ARWR) said that, it will present 2016 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting – Los Angeles, March 4-7, 2016.

Arrowhead Research Corp. (NASDAQ:ARWR) ended the last trading day at $4.14. Company weekly volatility is calculated as 5.99% and price to cash ratio as 3.22. Arrowhead Research Corp. (NASDAQ:ARWR) showed a weekly performance of 6.70%.

On 24 February, Innodata Inc. (NASDAQ:INOD) reported Total revenue was $15.5 million in the fourth quarter of 2015, a 3% sequential increase from $15.1 million in the third quarter of 2015 and an approximately 2% decline from $15.9 million in the fourth quarter of 2014.

Innodata Inc. (NASDAQ:INOD) shares moved up 0.43% in last trading session and ended the day at $2.31. INOD Gross Margin is 25.00% and its return on assets is -4.70%. Innodata Inc. (NASDAQ:INOD) quarterly performance is -18.66%.

Leave a Reply

Your email address will not be published. Required fields are marked *